These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 26720029)
1. Pharmacologic Management of Irritable Bowel Syndrome. Rao VL; Cifu AS; Yang LW; JAMA; 2015 Dec 22-29; 314(24):2684-5. PubMed ID: 26720029 [No Abstract] [Full Text] [Related]
2. American Gastroenterological Association Institute Technical Review on the pharmacological management of irritable bowel syndrome. Chang L; Lembo A; Sultan S Gastroenterology; 2014 Nov; 147(5):1149-72.e2. PubMed ID: 25224525 [No Abstract] [Full Text] [Related]
3. American Gastroenterological Association Institute Guideline on the pharmacological management of irritable bowel syndrome. Weinberg DS; Smalley W; Heidelbaugh JJ; Sultan S; Gastroenterology; 2014 Nov; 147(5):1146-8. PubMed ID: 25224526 [No Abstract] [Full Text] [Related]
4. The use of mebeverine in irritable bowel syndrome. A Position paper of the Romanian Society of Neurogastroenterology based on evidence. Dumitrascu DL; Chira A; Bataga S; Diculescu M; Drug V; Gheorghe C; Goldis A; Nedelcu L; Porr PJ; Sporea I; J Gastrointestin Liver Dis; 2014 Dec; 23(4):431-5. PubMed ID: 25532003 [No Abstract] [Full Text] [Related]
5. Evaluation of harm in the pharmacotherapy of irritable bowel syndrome. Shah E; Kim S; Chong K; Lembo A; Pimentel M Am J Med; 2012 Apr; 125(4):381-93. PubMed ID: 22444104 [TBL] [Abstract][Full Text] [Related]
6. FDA approves one drug for irritable bowel syndrome but suspends another. Harv Womens Health Watch; 2008 Aug; 15(12):7. PubMed ID: 19115501 [No Abstract] [Full Text] [Related]
7. Alosetron in irritable bowel syndrome: strategies for its use in a common gastrointestinal disorder. Lembo A; Weber HC; Farraye FA Drugs; 2003; 63(18):1895-905. PubMed ID: 12930162 [TBL] [Abstract][Full Text] [Related]
8. Rifaximin (Xifaxan) for Irritable Bowel Syndrome. Karuppiah S; Pomianowski K Am Fam Physician; 2017 Feb; 95(4):258-259. PubMed ID: 28290635 [No Abstract] [Full Text] [Related]
9. Current US Food and Drug Administration-Approved Pharmacologic Therapies for the Treatment of Irritable Bowel Syndrome with Diarrhea. Brenner DM; Sayuk GS Adv Ther; 2020 Jan; 37(1):83-96. PubMed ID: 31707713 [TBL] [Abstract][Full Text] [Related]
10. New drug approved for irritable bowel syndrome in women. Mayo Clin Womens Healthsource; 2004 Feb; 8(2):3. PubMed ID: 14722489 [No Abstract] [Full Text] [Related]
11. Review article: the role of antibiotics vs. conventional pharmacotherapy in treating symptoms of irritable bowel syndrome. Frissora CL; Cash BD Aliment Pharmacol Ther; 2007 Jun; 25(11):1271-81. PubMed ID: 17509095 [TBL] [Abstract][Full Text] [Related]
14. Lubiprostone (Amitiza) for irritable bowel syndrome with constipation. Med Lett Drugs Ther; 2008 Jul; 50(1290):53-4. PubMed ID: 18617872 [No Abstract] [Full Text] [Related]
15. Rifaximin and lubiprostone: the best options for treating irritable bowel syndrome? Purslow C Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):263. PubMed ID: 22816171 [No Abstract] [Full Text] [Related]
16. Τ Eluxadoline for IBS-D. Drug Ther Bull; 2017 Aug; 55(8):91-92. PubMed ID: 28808082 [No Abstract] [Full Text] [Related]
17. Effective management of irritable bowel syndrome--the Manchester Model. Whorwell PJ Int J Clin Exp Hypn; 2006 Jan; 54(1):21-6. PubMed ID: 16316881 [TBL] [Abstract][Full Text] [Related]
18. How can we achieve relief of bowel and abdominal symptoms for patients with irritable bowel syndrome with constipation? Tack J Expert Rev Gastroenterol Hepatol; 2013 Jul; 7(5 Suppl 1):21-6. PubMed ID: 23859757 [TBL] [Abstract][Full Text] [Related]
19. Safety and tolerability of tegaserod in irritable bowel syndrome management. Berardi RR J Am Pharm Assoc (2003); 2004; 44(1):41-51. PubMed ID: 14965152 [TBL] [Abstract][Full Text] [Related]
20. [Drug therapy for irritable bowel syndrome. What works, what doesn't work and for whom?]. Mönnikes H; Schmidtmann M; van der Voort IR Internist (Berl); 2006 Oct; 47(10):1073-6, 1078-83. PubMed ID: 16988806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]